Molecular Signaling group is interested in discovery and exploring cancer drug targets through molecular signal processing.
Our overall goals are to identify and characterize pharmacologically new agonists and antagonists for the receptor and explore their potential for treating human cancer conditions. To reach this goal, we integrate both experimental and computational expertise within our research group.
Group leader is PhD, docent Meenakshisundaram Kandhavelu.